deferoxamine has been researched along with Porphyria Cutanea Tarda in 8 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, L | 1 |
| Macrì, A | 1 |
| Lupia Palmieri, G | 1 |
| Aurizi, C | 1 |
| Biolcati, G | 1 |
| Labidi, J | 1 |
| Pitche, P | 1 |
| Corrin, E | 1 |
| Wolkenstein, P | 1 |
| Revuz, J | 1 |
| Bagot, M | 1 |
| HOLZMANN, H | 1 |
| SAUNDERS, SJ | 1 |
| Köstler, E | 1 |
| Wollina, U | 1 |
| Peces, R | 1 |
| Enríquez de Salamanca, R | 1 |
| Fontanellas, A | 1 |
| Sánchez, A | 1 |
| de la Torre, M | 1 |
| Caparros, G | 1 |
| Ferreras, I | 1 |
| Nieto, J | 1 |
| Sivakumaran, M | 1 |
| Hudson, P | 1 |
1 review available for deferoxamine and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
Therapy of porphyria cutanea tarda.
Topics: Chloroquine; Deferoxamine; Erythropoietin; Humans; Iron; Phlebotomy; Porphyria Cutanea Tarda; Renal | 2005 |
7 other studies available for deferoxamine and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
Association between porphyria cutanea tarda and beta-thalassemia major.
Topics: Adult; Anemia; beta-Thalassemia; Chloroquine; Deferoxamine; Female; Hepatitis C; Humans; Iron Overlo | 2009 |
Porphyria cutanea tarda in a chronic hemodialysis patient.
Topics: Adult; Biomarkers; Biopsy; Deferoxamine; Female; Ferritins; Fluorescent Antibody Technique; Hemoglob | 2010 |
[Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine].
Topics: Deferoxamine; Humans; Iron Chelating Agents; Male; Middle Aged; Porphyria Cutanea Tarda; Remission I | 2003 |
[On the use of desferrioxamine in porphyria cutanea tarda].
Topics: Animals; Chelating Agents; Deferoxamine; Humans; Hydroxamic Acids; Porifera; Porphyria Cutanea Tarda | 1963 |
IRON METABOLISM IN SYMPTOMATIC PORPHYRIA. A PRELIMINARY COMMUNICATION.
Topics: Alcoholism; Blood Chemical Analysis; Chelating Agents; Deferoxamine; Feces; Hemochromatosis; Hexachl | 1963 |
Successful treatment of haemodialysis-related porphyria cutanea tarda with erythropoietin.
Topics: Deferoxamine; Erythropoietin; Female; Humans; Middle Aged; Porphyria Cutanea Tarda; Recombinant Prot | 1994 |
Blood and blisters: porphyria cutanea tarda in myelodysplastic syndrome.
Topics: Aged; Aged, 80 and over; Anemia, Refractory; Deferoxamine; Female; Hand Dermatoses; Humans; Iron Che | 2002 |